Related Experiment Videos
Carboquone therapy for hematologic neoplasms
The Tohoku Journal of Experimental Medicine
|October 1, 1982
Abstract:
A daily oral dose of 1-2 mg of Carboquone was administered for remission induction to 38 patients with hematologic malignancy, and the following results were obtained: 2 of the 3 patients with malignant lymphoma, 1 of the 12 patients with multiple myeloma, 13 of the 14 patients with chronic myelogenous leukemia, and all 9 patients with polycythemia vera attained complete remission.